410I

UBIGEL WOMEN 50 ML

UBIGEL WOMEN 50 ML

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

UBIGEL
WOMAN

Description
A medical device based on a complex of hyaluronic acid and spermidine indicated for the treatment of female genitourinary syndromes. Hyaluronic acid is a physiological biopolymer composed of glycosaminoglycans typical of the extracellular matrix.
By hydrating, it binds large amounts of water, thus contributing to the integrity of epithelial and connective tissues. The complex releases spermidine in a "sustained" form, which supports physiological renewal processes. Spermidine is a metabolite essential to physiology through the regulation of vital cellular processes. It is present in genitourinary tissues, although it may be a limited/limiting factor, where exogenous intake thus becomes "restorative" of the physiological condition. The action of spermidine creates microenvironmental conditions that induce stress on cellular mechanosensors. This mode of action evokes a positive micromechanical stimulation (therefore comparable to a form of "soft" internal gymnastics) that leads to progressive vulvar, urethral, ​​and vaginal re-education.
Ubigel Donna improves and supports genitourinary trophism with high bioadhesive properties on tissues, forming a trophic film capable of supporting the recompaction of the epithelial and connective tissue layers. Ubigel Donna adheres to the genitourinary tissues, progressively reducing perceived discomfort. The product's nature allows it to be used in conjunction with treatments aimed at vaginal infections. For use in cases of vulvodynia.

How to use
Apply every other day for 4 weeks. After a one-week break, resume with one application every 3 days for another 4 weeks. Discontinue use if symptoms resolve prematurely. Occasional use with sporadic applications is recommended to maintain the benefits achieved after treatment.
- Unscrew the cap and pierce the seal with the back of the cap.
- Press in the direction of the finger of the opposite hand, depositing approximately 1 cm of gel.
- Apply a quantity of gel equal to 2 g of product.
- Apply with a short massage to the vulvar area and leave to absorb for about two minutes.

Components
Water, spermidine hyaluronate, benzyl alcohol, sodium benzoate, phenoxyethanol, citric acid.

Warnings
This product is intended for topical use only. Do not use by any route other than that indicated in this leaflet. Do not use in pregnant women without first consulting a doctor. Do not use the product after the expiration date shown on the package. Do not use the tube if it is broken or damaged. Keep out of reach of children.

Conservation
Store between 4°C and 30°C. Close the tube after use.
Shelf life of intact packaging: 36 months.
Shelf life after opening: 6 months.

Format
50 ml.

Code UDON50

410I

UBIGEL WOMEN 50 ML

UBIGEL WOMEN 50 ML

MINSAN code: 987869880
EAN Code: 8053614600007
Previous price: €56,76
Regular price €56,76
Regular price €59,00 Sale price €56,76
-3% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.